Clinical Scorecard: Esophageal Motility Disorders and Achalasia in Patients Undergoing Bariatric Surgery: A Retrospective Descriptive Analysis

At a Glance

Key Highlights

• Achalasia occurs in up to 1% of individuals with severe obesity and may coexist or develop before, after, or concurrently with bariatric surgery.
• Bariatric surgery alters foregut anatomy and physiology, potentially unmasking or inducing EMDs including achalasia and post-obesity esophageal dysfunction (POSED).
• Treatment sequencing (achalasia-first vs bariatric-first) influences clinical outcomes including symptom resolution, weight loss, and complication rates.

Guideline-Based Recommendations

Diagnosis

• Use high-resolution manometry (HRM) interpreted with clinical context and Chicago Classification v4.0 for EMDs diagnosis when data are complete.
• Employ upper endoscopy and timed barium esophagogram as adjunctive diagnostic tools when clinically indicated.
• Classify patients with incomplete manometric data conservatively as EMDs rather than classic achalasia to avoid diagnostic overstatement.

Management

• Individualize achalasia treatment modality (POEM, Heller myotomy, pneumatic dilation, botulinum toxin) based on subtype, prior anatomy, and symptom severity.
• Perform partial fundoplication with Heller myotomy prior to bariatric surgery; take down fundoplication during Roux-en-Y gastric bypass to facilitate pouch creation.
• Avoid routine bilateral truncal vagotomy during gastric bypass.
• Use acid suppression therapy postoperatively in patients with prior sleeve gastrectomy undergoing myotomy without anti-reflux procedure.

Monitoring & Follow-up

• Assess symptom resolution based on patient-reported improvement in dysphagia and related symptoms documented in clinical notes.
• Monitor weight loss metrics including percentage of total weight loss (%TWL) at one year and last follow-up.
• Track bariatric surgery-related complications and need for reintervention longitudinally.

Risks

• Potential for post-obesity esophageal dysfunction (POSED) in up to 40% of cases after bariatric surgery.
• Risk of de novo achalasia or other EMDs induced by anatomical changes from bariatric procedures.
• Diagnostic and therapeutic challenges due to overlapping symptoms of obesity, GERD, and EMDs.

Patient & Prescribing Data

Patients with severe obesity undergoing bariatric surgery who also require treatment for achalasia or EMDs.

Treatment sequencing (achalasia-first vs bariatric-first) impacts symptom response, weight loss outcomes, and complication rates; individualized multidisciplinary planning is essential.

Clinical Best Practices

• Systematically screen for esophageal motility disorders in bariatric surgery candidates presenting with dysphagia or related symptoms.
• Use multidisciplinary teams involving foregut and bariatric specialists to tailor treatment sequencing and modality.
• Interpret HRM results in the context of altered foregut anatomy post-bariatric surgery to avoid misdiagnosis.
• Customize surgical approaches including fundoplication and acid suppression based on prior bariatric procedures.
• Document patient-reported symptom improvement carefully as standardized symptom scores may be confounded by weight loss.

References

• Chicago Classification version 4.0 for esophageal motility disorders